BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20026052)

  • 1. Decorin is processed by three isoforms of bone morphogenetic protein-1 (BMP1).
    von Marschall Z; Fisher LW
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1374-8. PubMed ID: 20026052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective Proteolytic Processing of Fibrillar Procollagens and Prodecorin Due to Biallelic BMP1 Mutations Results in a Severe, Progressive Form of Osteogenesis Imperfecta.
    Syx D; Guillemyn B; Symoens S; Sousa AB; Medeira A; Whiteford M; Hermanns-Lê T; Coucke PJ; De Paepe A; Malfait F
    J Bone Miner Res; 2015 Aug; 30(8):1445-56. PubMed ID: 25656619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dentin sialophosphoprotein (DSPP) is cleaved into its two natural dentin matrix products by three isoforms of bone morphogenetic protein-1 (BMP1).
    von Marschall Z; Fisher LW
    Matrix Biol; 2010 May; 29(4):295-303. PubMed ID: 20079836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein-1 processes probiglycan.
    Scott IC; Imamura Y; Pappano WN; Troedel JM; Recklies AD; Roughley PJ; Greenspan DS
    J Biol Chem; 2000 Sep; 275(39):30504-11. PubMed ID: 10896944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMP1-like proteinases are essential to the structure and wound healing of skin.
    Muir AM; Massoudi D; Nguyen N; Keene DR; Lee SJ; Birk DE; Davidson JM; Marinkovich MP; Greenspan DS
    Matrix Biol; 2016 Dec; 56():114-131. PubMed ID: 27363389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential cleavage of lysyl oxidase by the metalloproteinases BMP1 and ADAMTS2/14 regulates collagen binding through a tyrosine sulfate domain.
    Rosell-García T; Paradela A; Bravo G; Dupont L; Bekhouche M; Colige A; Rodriguez-Pascual F
    J Biol Chem; 2019 Jul; 294(29):11087-11100. PubMed ID: 31152061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular BMP1 is the major proteinase for COOH-terminal proteolysis of type I procollagen in lung fibroblasts.
    N'Diaye EN; Cook R; Wang H; Wu P; LaCanna R; Wu C; Ye Z; Seshasayee D; Hazen M; Lin W; Tyagi T; Hotzel I; Tam L; Newman R; Roose-Girma M; Wolters PJ; Ding N
    Am J Physiol Cell Physiol; 2021 Feb; 320(2):C162-C174. PubMed ID: 33206546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP1 is not required for lung fibrosis in mice.
    Ma HY; N'Diaye EN; Caplazi P; Huang Z; Arlantico A; Jeet S; Wong A; Brightbill HD; Li Q; Wong WR; Sandoval W; Tam L; Newman R; Roose-Girma M; Ding N
    Sci Rep; 2022 Mar; 12(1):5466. PubMed ID: 35361882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural correlations in the family of small leucine-rich repeat proteins and proteoglycans.
    McEwan PA; Scott PG; Bishop PN; Bella J
    J Struct Biol; 2006 Aug; 155(2):294-305. PubMed ID: 16884925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin binds and enhances the activity of bone morphogenetic protein 1.
    Huang G; Zhang Y; Kim B; Ge G; Annis DS; Mosher DF; Greenspan DS
    J Biol Chem; 2009 Sep; 284(38):25879-88. PubMed ID: 19617627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental roles of the BMP1/TLD metalloproteinases.
    Ge G; Greenspan DS
    Birth Defects Res C Embryo Today; 2006 Mar; 78(1):47-68. PubMed ID: 16622848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures.
    Uzel MI; Scott IC; Babakhanlou-Chase H; Palamakumbura AH; Pappano WN; Hong HH; Greenspan DS; Trackman PC
    J Biol Chem; 2001 Jun; 276(25):22537-43. PubMed ID: 11313359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a mutation causing deficient BMP1/mTLD proteolytic activity in autosomal recessive osteogenesis imperfecta.
    Martínez-Glez V; Valencia M; Caparrós-Martín JA; Aglan M; Temtamy S; Tenorio J; Pulido V; Lindert U; Rohrbach M; Eyre D; Giunta C; Lapunzina P; Ruiz-Perez VL
    Hum Mutat; 2012 Feb; 33(2):343-50. PubMed ID: 22052668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating bone morphogenetic protein 1-3 isoform increases renal fibrosis.
    Grgurevic L; Macek B; Healy DR; Brault AL; Erjavec I; Cipcic A; Grgurevic I; Rogic D; Galesic K; Brkljacic J; Stern-Padovan R; Paralkar VM; Vukicevic S
    J Am Soc Nephrol; 2011 Apr; 22(4):681-92. PubMed ID: 21415150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of bone morphogenetic protein 1 (Bmp1) and tolloid-like 1 (Tll1) in cells expressing type I collagen leads to dental and periodontal defects in mice.
    Zhang H; Jani P; Liang T; Lu Y; Qin C
    J Mol Histol; 2017 Apr; 48(2):83-98. PubMed ID: 28000152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DSP-PP precursor protein cleavage by tolloid-related-1 protein and by bone morphogenetic protein-1.
    Ritchie HH; Yee CT; Tang XN; Dong Z; Fuller RS
    PLoS One; 2012; 7(7):e41110. PubMed ID: 22815932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of bone morphogenetic protein 1 by native and altered forms of alpha2-macroglobulin.
    Zhang Y; Ge G; Greenspan DS
    J Biol Chem; 2006 Dec; 281(51):39096-104. PubMed ID: 17071617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Bmp1/Tll1 doubly homozygous null mice and proteomics to identify and validate in vivo substrates of bone morphogenetic protein 1/tolloid-like metalloproteinases.
    Pappano WN; Steiglitz BM; Scott IC; Keene DR; Greenspan DS
    Mol Cell Biol; 2003 Jul; 23(13):4428-38. PubMed ID: 12808086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two novel compound heterozygous BMP1 mutations in a patient with osteogenesis imperfecta: a case report.
    Sangsin A; Kuptanon C; Srichomthong C; Pongpanich M; Suphapeetiporn K; Shotelersuk V
    BMC Med Genet; 2017 Mar; 18(1):25. PubMed ID: 28257626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed inhibition of collagen deposition by targeting bone morphogenetic protein 1 promotes recovery after spinal cord injury.
    Huang Y; Gao P; Qin T; Chu B; Xu T; Yi J; Wang Q; Yang Z; Jiang T; Fan J; Zhao S; Zhou W; Chen J; Yin G
    Matrix Biol; 2023 Apr; 118():69-91. PubMed ID: 36918086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.